As we begin a new year, we are pleased to share the latest developments, achievements, and initiatives that have marked the first quarter of 2026. This edition highlights the progress we have made in advancing metabolomics and precision medicine through scientific excellence, innovation, and collaboration.
Over the past three months, Biosfer Teslab has continued to strengthen its research capabilities, expand collaborations, participate in key scientific events, and enhance its portfolio of services. These milestones reflect our ongoing commitment to providing cutting-edge solutions that support researchers, healthcare professionals, and industry partners.
We hope this newsletter keeps you informed about our latest activities and inspires new opportunities for collaboration. Thank you for being part of the Biosfer Teslab community and for joining us as we continue to drive innovation in metabolomics and precision medicine.
